{"schema_version":"secwatch.filing_event.v1","accession":"0001689548-24-000073","form_type":"8-K","ticker":"PRAX","cik":"0001689548","company_name":"Praxis Precision Medicines, Inc.","filed_at":"2024-06-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.591989+00:00","generated_at":"2026-06-01T05:55:54.620424+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Praxis Precision Medicines shareholders approve 870K share increase for 2020 equity plan","bullets":["Stockholders elected Dean Mitchell and Jill DeSimone as Class I directors for terms ending 2027.","Ratified Ernst & Young as independent auditor for FY 2024 with 15.3M votes for.","Approved amendment to 2020 Stock Plan, increasing authorized shares by 870,000 (9.1M for, 5.1M against).","Advisory vote on executive compensation passed with 10.0M for, 4.1M against."],"urls":{"canonical":"https://secwatch.observer/filing/0001689548-24-000073","json":"https://secwatch.observer/filing/0001689548-24-000073.json","markdown":"https://secwatch.observer/filing/0001689548-24-000073.md","text":"https://secwatch.observer/filing/0001689548-24-000073.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1689548/000168954824000073/0001689548-24-000073-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1689548/000168954824000073/prax-20240605.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:55:54.620424+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}